Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Meta-analysis comparing incidence of grade 3-4 neutropenia with ALK inhibitors and chemotherapy in patients with non-small-cell lung cancer.

Rapoport B, Arani RB, Mathieson N, Krendyukov A.

Future Oncol. 2019 Jun;15(18):2163-2174. doi: 10.2217/fon-2018-0863. Epub 2019 May 22.

2.

Characterization of renal biomarkers for use in clinical trials: effect of preanalytical processing and qualification using samples from subjects with diabetes.

Brott DA, Furlong ST, Adler SH, Hainer JW, Arani RB, Pinches M, Rossing P, Chaturvedi N; DIRECT Programme Steering Committee.

Drug Des Devel Ther. 2015 Jun 22;9:3191-8. doi: 10.2147/DDDT.S78792. eCollection 2015.

3.

Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis.

Baker RA, Pikalov A, Tran QV, Kremenets T, Arani RB, Doraiswamy PM.

Psychopharmacol Bull. 2009;42(1):11-31.

PMID:
19204649
4.

Clinical applications for change-point analysis of herpes zoster pain.

Desmond RA, Weiss HL, Arani RB, Soong SJ, Wood MJ, Fiddian PA, Gnann JW, Whitley RJ.

J Pain Symptom Manage. 2002 Jun;23(6):510-6.

PMID:
12067775
5.

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, Saag MS, Wu X, Shaw GM, Kappes JC.

Antimicrob Agents Chemother. 2002 Jun;46(6):1896-905.

6.

Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis.

Eubanks V, Koppersmith N, Wooldridge N, Clancy JP, Lyrene R, Arani RB, Lee J, Moldawer L, Atchison J, Sorscher EJ, Makris CM.

J Pediatr. 2002 Apr;140(4):439-44.

PMID:
12006958
7.

Phase specific analysis of herpes zoster associated pain data: a new statistical approach.

Arani RB, Soong SJ, Weiss HL, Wood MJ, Fiddian PA, Gnann JW, Whitley R.

Stat Med. 2001 Aug 30;20(16):2429-39.

PMID:
11512133
8.

Noninvasive characterization of stunned, hibernating, remodeled and nonviable myocardium in ischemic cardiomyopathy.

Narula J, Dawson MS, Singh BK, Amanullah A, Acio ER, Chaudhry FA, Arani RB, Iskandrian AE.

J Am Coll Cardiol. 2000 Nov 15;36(6):1913-9.

9.

Adenoviral-mediated suicide gene therapy for ovarian cancer.

Alvarez RD, Gomez-Navarro J, Wang M, Barnes MN, Strong TV, Arani RB, Arafat W, Hughes JV, Siegal GP, Curiel DT.

Mol Ther. 2000 Nov;2(5):524-30.

10.

A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial.

Alvarez RD, Barnes MN, Gomez-Navarro J, Wang M, Strong TV, Arafat W, Arani RB, Johnson MR, Roberts BL, Siegal GP, Curiel DT.

Clin Cancer Res. 2000 Aug;6(8):3081-7.

11.

Down-regulation of cell surface receptors is modulated by polar residues within the transmembrane domain.

Zaliauskiene L, Kang S, Brouillette CG, Lebowitz J, Arani RB, Collawn JF.

Mol Biol Cell. 2000 Aug;11(8):2643-55.

12.

Weighted p-value adjustments for animal carcinogenicity trend test.

Chen JJ, Lin KK, Huque M, Arani RB.

Biometrics. 2000 Jun;56(2):586-92.

PMID:
10877321
13.

Induction of anti-tumor immunity by intrasplenic administration of a carcinoembryonic antigen DNA vaccine.

White SA, LoBuglio AF, Arani RB, Pike MJ, Moore SE, Barlow DL, Conry RM.

J Gene Med. 2000 Mar-Apr;2(2):135-40.

PMID:
10809147
14.

Paternal body fat is a longitudinal predictor of changes in body fat in premenarcheal girls.

Figueroa-Colon R, Arani RB, Goran MI, Weinsier RL.

Am J Clin Nutr. 2000 Mar;71(3):829-34.

PMID:
10702180
15.

Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal versus subcutaneous administration.

Conry RM, Khazaeli MB, Saleh MN, Allen KO, Barlow DL, Moore SE, Craig D, Arani RB, Schlom J, LoBuglio AF.

Clin Cancer Res. 1999 Sep;5(9):2330-7.

16.

Ionizing radiation improves survival in mice bearing intracranial high-grade gliomas injected with genetically modified herpes simplex virus.

Bradley JD, Kataoka Y, Advani S, Chung SM, Arani RB, Gillespie GY, Whitley RJ, Markert JM, Roizman B, Weichselbaum RR.

Clin Cancer Res. 1999 Jun;5(6):1517-22.

17.
18.

A result on a 2 x 2 survival experiment.

Arani RB, Rao MB.

Math Biosci. 1997 Dec;146(2):63-73. Erratum in: Math Biosci 1999 Apr;158(1):93.

PMID:
9348739

Supplemental Content

Loading ...
Support Center